IMUX Immunic, Inc.
Company Analysis
Latest News
🔴 Immunic is trading 5% down today amid broader risk-off sentiment
Immunic is trading 5.02% down now at $12.10, with the decline most consistent with broader risk-off sentiment. - Its September 9, 2026 virtual R&D Day will...
🟢 Immunic is trading 5.42% up in pre-market ahead of September 9, 2026 virtual R&D Day
Immunic is trading 5.42% up at $13.43 ahead of its scheduled September 9, 2026 virtual R&D Day. - The event will discuss relapsing multiple sclerosis and lead...
🔴 Immunic is trading 5% down today with no clear catalyst identified
Immunic is trading 5.03% down now at $12.45, with no clear company-specific catalyst identified as of September 8, 2026. - No company-specific announcement,...
🔴 Immunic is trading 10% down today with no confirmed company-specific catalyst
Immunic is trading 10.46% down at $12.75 now, with no confirmed company-specific negative catalyst emerging for September 3, 2026. - The latest announcement,...
🔴 Immunic is trading 5% down today; no confirmed trigger identified
Immunic is trading at $13.51, down -5.13%, with the move appearing driven by stock-specific trading or profit-taking. - No new negative company-specific...
🟢 Immunic is trading 6.46% up in after-hours trading after announcing September 9 multiple-sclerosis R&D Day
Immunic is trading 6.46% up now at $15.16 after announcing a September 9 virtual R&D Day focused on relapsing multiple sclerosis. - The event comes ahead of...
🔴 Immunic is trading 5.19% down today as biotech stocks sell off
Immunic is trading 5.19% down at $14.98 after broader risk-off pressure hit biotechnology and growth stocks on September 1, 2026. - Biotech ETF XBI is down...
🔴 Immunic is trading 5.52% down today amid biotech weakness ahead of Kevin Warsh’s speech
Immunic is trading 5.52% down at $15.40 amid broad weakness across biotechnology stocks. - No new company-specific announcement, financing, clinical,...
🔴 Immunic is trading 12.07% down in pre-market with no company news or clear market-wide explanation
Immunic is trading at $14.50, down -12.07%, with no company news or clear market-wide explanation identified. - No August 26–27, 2026 company news was listed...
🟢 Immunic is trading 5.36% up today after Wedbush initiated Outperform coverage
Immunic is trading 5.36% up at $16.89 after Wedbush initiated coverage on August 17, 2026, with an Outperform rating and a $45 price target. - H.C. Wainwright...
Immunic Gains Analyst Confidence with Positive Forecasts and New 'Outperform' Rating
Immunic, Inc. saw a boost in analyst confidence on Monday. HC Wainwright significantly raised its earnings per share forecasts for the company, now projecting...
🟢 Immunic is trading 5% up today after beating Q2 EPS expectations
Immunic is trading at $16.75, up +5.15%, after investors continued responding to its August 11, 2026, Q2 results and smaller-than-expected loss per share. •...
🟢 Immunic surges 6.5% after Q2 earnings beat estimates and reaffirms year-end Phase 3 data
- Immunic's Q2 report on August 11, 2026, showed a GAAP EPS of -$0.80, beating analyst estimates of -$1.16 by $0.36. - The company reaffirmed that top-line...
🟢 Immunic is trading 5% up today after surpassing second-quarter expectations
Immunic is trading 5.32% up now at $14.85 after reporting second-quarter results that surpassed Wall Street expectations. - Reported an $0.80 loss per share...
Immunic's second quarter 2026 loss per share narrows to $0.80 as Phase 3 trials progress
Immunic reported a net loss of $34.1 million for the second quarter of 2026, as the company intensified investments in its late-stage multiple sclerosis...
🟢 Immunic is trading 6.53% up today on renewed biotech M&A optimism
Immunic is trading 6.53% up at $15.49, extending the August 6, 2026 advance as biotech shares rally on renewed merger-and-acquisition optimism. - No fresh...
🟢 Immunic is trading 5.4% up today amid renewed biotech M&A optimism
Immunic is trading 5.4% up at $14.77, with the move driven primarily by a biotech-sector rally. - Biotech ETF XBI is up 2.09% on August 6, 2026, following...
Immunic, Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 06, 2026
Immunic, Inc. (IMUX) is expected to report a consensus EPS of -$1.24 on zero revenue, with the current stock price of $14.05 trading significantly below the...
🟢 Immunic is trading 5.1% up today amid a broad tech rally and cooling inflation data
Immunic is trading 5.1% up at $13.71 as U.S. equities rebound following upbeat tech earnings and favorable economic data. • The broader market is seeing...
🔴 Immunic is trading 5.1% down today on profit-taking following a sector-driven rebound
Immunic is trading 5.1% down at $13.01 as the stock faces profit-taking following yesterday’s biotech-driven rebound. • The decline appears to reflect a shift...